Animal Health One 2020 | Kisaco Research

Animal Health Investment One

International business partnering. Delivered virtually.

Book Now
VIRTUAL EVENT | EDT Timezone
23-25 June, 2020

The first virtual event from Animal Health Investment Online, Animal Health Investment One will provide a valuable platform for discussion, networking and partnering in these uncertain times.

Why Attend

The Covid-19 pandemic is creating unprecedented disruption for the animal health industry with far reaching effects yet to be measured. In this uncertain time, there is a now a real need for greater collaboration and communication across the sector and among emerging businesses, large corporate entities, government agencies, NGOs, and investors.

At Kisaco Research we're committed to giving the animal health community a platform where we can come together, continue to create vital strategic connections and drive deal-making via virtual partnering meetings. We appreciate that this will be a new experience for many of you but operating virtually is now the new business norm and we look forward to working with you to make this a truly effective experience. 

Join us virtually June 23rd -25th and access:

  • 3 days of advanced, pre-scheduled, virtual networking using 1-2-1 video chat
  • Highly relevant and informative content sessions, panel discussions and presentations
  • An international business audience specific to animal health and nutrition
  • The opportunity to engage with the most exciting emerging business and biotech in animal health
100+
Attendees
20+
Speakers
7+
Hours of Networking

Speakers

 

Sébastien Huron

Chairman of the Executive Board
Virbac Santé Animale

Sébastien Huron, 46, DVM, started his career in 1994 in Brazil in the Hoechst-Roussel group where he rapidly rose to become the Marketing director of the animal health division. After Intervet acquired this division (Akzo Nobel group), which was then integrated into the Merck Group, Sébastien Huron pursued his career in 2000 in the United States as Market Development director, and then as director of the Pet division.

Sébastien Huron

Chairman of the Executive Board
Virbac Santé Animale

Sébastien Huron

Chairman of the Executive Board
Virbac Santé Animale

Sébastien Huron, 46, DVM, started his career in 1994 in Brazil in the Hoechst-Roussel group where he rapidly rose to become the Marketing director of the animal health division. After Intervet acquired this division (Akzo Nobel group), which was then integrated into the Merck Group, Sébastien Huron pursued his career in 2000 in the United States as Market Development director, and then as director of the Pet division. After rejoining the Virbac group in 2006 as the general manager of the Spanish subsidiary, he then became the director of the European region in 2008, and then head of Global Business Operations in 2013. He has been part of the Virbac executive board since December 2012.

 

Rimma Driscoll

Senior Vice President, Global Business Development
Zoetis

Rimma Driscoll is an executive in Global Business Development and Strategic Alliances with 20+ years in the field. Rimma has a depth of experience in a broad range of global transactions including JVs,Strategic Alliances, Collaborations, Acquisitions, Divestitures, Licensing Deals, and Partnerships. This experience span from small Discovery deals to multi-billionaire dollar divestitures. Rimma guides Multi-function teams on the external strategies and then leads all aspects of negotiations, and leverages external relationships to bring transactions to closure.

Rimma Driscoll

Senior Vice President, Global Business Development
Zoetis

Rimma Driscoll

Senior Vice President, Global Business Development
Zoetis

Rimma Driscoll is an executive in Global Business Development and Strategic Alliances with 20+ years in the field. Rimma has a depth of experience in a broad range of global transactions including JVs,Strategic Alliances, Collaborations, Acquisitions, Divestitures, Licensing Deals, and Partnerships. This experience span from small Discovery deals to multi-billionaire dollar divestitures. Rimma guides Multi-function teams on the external strategies and then leads all aspects of negotiations, and leverages external relationships to bring transactions to closure. She has worked extensively in Pharmaceuticals, Consumer Healthcare and Consumer Products businesses.

 

Georgia Wraight

Executive Vice President and President, Global Technology Solutions
Covetrus

Georgia Wraight

Executive Vice President and President, Global Technology Solutions
Covetrus

Georgia Wraight

Executive Vice President and President, Global Technology Solutions
Covetrus
 

Paul Koffman

Vice President – North American Livestock Monitoring
Allflex Livestock Intelligence

Paul Koffman

Vice President – North American Livestock Monitoring
Allflex Livestock Intelligence

Paul Koffman

Vice President – North American Livestock Monitoring
Allflex Livestock Intelligence
 

David Prien

CEO
FirstVet

David founded FirstVet in 2016 and has previously run several pet-related startups in the Nordics, taking them from early stages to exits. Graduated from SSE with a double degree in Business & Retail Management.

David Prien

CEO
FirstVet

David Prien

CEO
FirstVet

David founded FirstVet in 2016 and has previously run several pet-related startups in the Nordics, taking them from early stages to exits. Graduated from SSE with a double degree in Business & Retail Management.

 

Mark Boddy

CEO
PawSquad

Mark Boddy

CEO
PawSquad

Mark Boddy

CEO
PawSquad
 

Victoria Johnson

Victoria Johnson Director
VetCT

Victoria Johnson

Victoria Johnson Director
VetCT

Victoria Johnson

Victoria Johnson Director
VetCT
 

Roy Stein

CEO
BabelBark

Roy Stein

CEO
BabelBark

Roy Stein

CEO
BabelBark
 

Anton Xavier

Founder and CEO
K9 Biotech

Anton Xavier

Founder and CEO
K9 Biotech

Anton Xavier

Founder and CEO
K9 Biotech
 

Ricky Ghoshal

Vice President, Business Development
Glysantis Inc.

Ricky Ghoshal

Vice President, Business Development
Glysantis Inc.

Ricky Ghoshal

Vice President, Business Development
Glysantis Inc.
 

Chris Belnap

CEO and Co-Founder
Resilient Biotics

Chris Belnap

CEO and Co-Founder
Resilient Biotics

Chris Belnap

CEO and Co-Founder
Resilient Biotics
 

Rob Readnour

Managing Director
Mountain Group Capital Partners

Dr. Readnour currently serves on or has visitation rights to the following companies: AgTech Accelerator, a unique startup accelerator focused on discovering and developing emerging agricultural technology companies, Skyline Vet Pharma, a company that is developing veterinary pharmaceuticals using proven delivery technologies to reformulate drugs with established animal health markets, and Boragen, a company that is developing small molecule approaches focused on leveraging the unique chemical properties of boron chemistry, both in crop protection and animal health.

Rob Readnour

Managing Director
Mountain Group Capital Partners

Rob Readnour

Managing Director
Mountain Group Capital Partners

Dr. Readnour currently serves on or has visitation rights to the following companies: AgTech Accelerator, a unique startup accelerator focused on discovering and developing emerging agricultural technology companies, Skyline Vet Pharma, a company that is developing veterinary pharmaceuticals using proven delivery technologies to reformulate drugs with established animal health markets, and Boragen, a company that is developing small molecule approaches focused on leveraging the unique chemical properties of boron chemistry, both in crop protection and animal health.

Prior to joining MGP, Dr. Readnour worked at Elanco Animal Health for 27 years. During his Elanco tenure, he held several senior management positions in which he was responsible for developing and executing Elanco’s Research and Development strategies for entering several new business areas (companion animal pharmaceuticals, vaccines and enzymes). In 2017, these new business areas accounted for nearly 50% of Elanco’s $3.0 billion in sales. Dr. Readnour played an important role in Elanco’s acquisition and integration of Novartis Animal Health, Lohmann Animal Health, ChemGen and Janssen Animal Health. Within Elanco, Dr. Readnour led several initiatives to transform Research and Development through the piloting of new approaches to developing animal health products. He developed and led Elanco’s new technology scouting, acquisition and due diligence efforts. He pioneered a lean product development model which allowed Elanco to enter new areas of business without significant capital investment. He led initial efforts for Elanco to invest in early stage companies and partner with external funding sources to develop products with minimal initial investment from Elanco. Dr. Readnour served as a member of the Food and Agriculture Section of Bio International Board and as an External Advisory Board member for University of Illinois Animal Science Department.
Prior to entering management in Elanco, Dr. Readnour was an internationally recognized expert on animal health product development, analytical chemistry, human food safety and drug residues with 11 publications and 14 external presentations. Throughout his career, Dr. Readnour was responsible for the development and commercialization of 10 animal health products. Dr. Readnour received his PhD in Analytical Chemistry from University of Illinois in 1990.

 

Joseph Harvey

Editor
Animal Pharm

Joseph Harvey

Editor
Animal Pharm

Joseph Harvey

Editor
Animal Pharm
 

Michael Helmstetter

Founder, President and CEO
TechAccel, LLC

Dr. Michael Helmstetter is Co-Founder, President, and Chief Executive Officer of TechAccel LLC (Technology Acceleration Partners).

TechAccel is a technology and venture development company in the agriculture and animal health sectors. The company invests in or acquires new technology and funds science advancement programs with research university partners to assist in commercialization.

Michael Helmstetter

Founder, President and CEO
TechAccel, LLC

Michael Helmstetter

Founder, President and CEO
TechAccel, LLC

Dr. Michael Helmstetter is Co-Founder, President, and Chief Executive Officer of TechAccel LLC (Technology Acceleration Partners).

TechAccel is a technology and venture development company in the agriculture and animal health sectors. The company invests in or acquires new technology and funds science advancement programs with research university partners to assist in commercialization.

Michael also serves as Managing Partner of Covenant Animal Health Partners, a TechAccel subsidiary that focuses on development of “revenue-ready” animal health products for both companion and farm animals.

Before founding TechAccel, Michael served as the fifth President and Chief Executive Officer of MRIGlobal – one of the nation's most prominent research institutions. In his 14 years with MRIGlobal (formerly Midwest Research Institute), he led its growth from 2 to 17 national and international locations.

Michael has more than 30 years of experience working with the private sector and government agencies, including laboratory management positions at Applied Marine Research Laboratory in Norfolk, Va., and program management for the Harbor Branch Oceanographic Institution in Fort Pierce, Fla. He was President and Chairman of startup Brevard Teaching and Research Laboratories, a post he held until the company was acquired by MRIGlobal.

Michael received a Ph.D. in Chemical Toxicology/Oceanography from Old Dominion University and a B.S. in Biology from Allegheny College. He has been a panelist, keynote speaker, lecturer, reviewer to several journals, and is the author of numerous publications, articles, book chapters, and technical reports.

He has served on several boards, including Labconco Corp. Board of Directors and University of Missouri-Kansas City Board of Trustees, as well as numerous civic organizations. He is a contributing opinion writer for Forbes.com.

Michael lives in suburban Kansas City.

Email: [email protected]
LinkedIn www.linkedin.com/in/michaelhelmstetter/

 

Spencer Swayze

Managing Director
Paine Schwartz Partners, LLC

Spencer Swayze

Managing Director
Paine Schwartz Partners, LLC

Spencer Swayze

Managing Director
Paine Schwartz Partners, LLC
 

Brian Axe

Principal
NovaQuest Capital Management

Brian Axe

Principal
NovaQuest Capital Management

Brian Axe

Principal
NovaQuest Capital Management
 

Cindy Cole

Partner
Digitalis Ventures

Dr. Cindy Cole is a Technical Partner at Digitalis Ventures and an Associate Clinical Professor at the University of Florida. Prior to joining Digitalis she was in the animal health industry for many years holding senior leadership and R&D roles at Mars Petcare, Novartis Animal Health, IDEXX, and Piedmont Pharmaceuticals. Dr. Cole completed her DVM and PhD at the University of Florida and was on the faculty of the University of California, Davis and UF.

Cindy Cole

Partner
Digitalis Ventures

Cindy Cole

Partner
Digitalis Ventures

Dr. Cindy Cole is a Technical Partner at Digitalis Ventures and an Associate Clinical Professor at the University of Florida. Prior to joining Digitalis she was in the animal health industry for many years holding senior leadership and R&D roles at Mars Petcare, Novartis Animal Health, IDEXX, and Piedmont Pharmaceuticals. Dr. Cole completed her DVM and PhD at the University of Florida and was on the faculty of the University of California, Davis and UF.

 

Joost Matthijssen

Director of Venturing
Nutreco

Joost Matthijssen

Director of Venturing
Nutreco

Joost Matthijssen

Director of Venturing
Nutreco
 

Sarai Kemp

VP Business Development
Trendlines AgTech

As VP Business Development for Trendlines Agtech since 2012, Sarai Kemp is responsible for directing the business and financial development and fund-raising strategies and activities for early-stage portfolio companies developing innovative technologies and products in aquaculture, food production, biopesticides and agrochemicals, and other related sectors. Trendlines Agtech is part of The Trendlines Group (www.trendlines.com).

Sarai Kemp

VP Business Development
Trendlines AgTech

Sarai Kemp

VP Business Development
Trendlines AgTech

As VP Business Development for Trendlines Agtech since 2012, Sarai Kemp is responsible for directing the business and financial development and fund-raising strategies and activities for early-stage portfolio companies developing innovative technologies and products in aquaculture, food production, biopesticides and agrochemicals, and other related sectors. Trendlines Agtech is part of The Trendlines Group (www.trendlines.com). Trendlines invents, discovers, invests in, and incubates innovation-based medical and agricultural technologies, and is involved in all aspects of its portfolio companies from technology development to business building.

Sarai brings more than 12 years’ experience in agricultural, consumer goods, and high-tech industries, including in sales, marketing, and business development for international companies such as Afimilk and Keter Plastic. She has worked intensively with companies in East Asia.

Sarai received an MBA from Haifa University and a B.A. from Tel Aviv University.

 

Laëtitia Gerbe

Partner for Investments for AVF Fund
Seventure Partners

Laëtitia Gerbe

Partner for Investments for AVF Fund
Seventure Partners

Laëtitia Gerbe

Partner for Investments for AVF Fund
Seventure Partners
 

Joy Parr Drach

President & CEO
Advanced Animal Diagnostics

Joy Parr Drach

President & CEO
Advanced Animal Diagnostics

Joy Parr Drach

President & CEO
Advanced Animal Diagnostics
 

Daniella Dos Santos

President
British Veterinary Association

Daniella Dos Santos

President
British Veterinary Association

Daniella Dos Santos

President
British Veterinary Association
 

Maarten Goossens

Co-founder and Principal
Anterra Capital

Maarten is a Co-founder and Principal at Anterra Capital. He began his investing career as an Analyst within the Rabo Ventures team in 2009 and was primarily responsible for deal sourcing and execution, and portfolio management. 

Prior to joining Rabo Ventures, Maarten was an Analyst in the Rabobank-Rothschild M&A joint venture in London, where he focused on transactions in Food & Agriculture. 

Maarten holds a Masters of Business Administration from the Free University of Amsterdam, and has studied at the London School of Economics.

Maarten Goossens

Co-founder and Principal
Anterra Capital

Maarten Goossens

Co-founder and Principal
Anterra Capital

Maarten is a Co-founder and Principal at Anterra Capital. He began his investing career as an Analyst within the Rabo Ventures team in 2009 and was primarily responsible for deal sourcing and execution, and portfolio management. 

Prior to joining Rabo Ventures, Maarten was an Analyst in the Rabobank-Rothschild M&A joint venture in London, where he focused on transactions in Food & Agriculture. 

Maarten holds a Masters of Business Administration from the Free University of Amsterdam, and has studied at the London School of Economics.

 

Simon Doherty

Senior Vice President
British Veterinary Association

Simon Doherty, president of the British Veterinary Association (BVA) is a veterinary consultant and senior lecturer at Queen’s University Belfast.

With two decades of experience in veterinary practice, industry and academia, Simon is well positioned to represent the varied veterinary roles and diversity of BVA’s 18,000+ members.

Simon Doherty

Senior Vice President
British Veterinary Association

Simon Doherty

Senior Vice President
British Veterinary Association

Simon Doherty, president of the British Veterinary Association (BVA) is a veterinary consultant and senior lecturer at Queen’s University Belfast.

With two decades of experience in veterinary practice, industry and academia, Simon is well positioned to represent the varied veterinary roles and diversity of BVA’s 18,000+ members.

For three years, Simon was the Animal Sciences & Aquaculture specialist for the Department for International Trade. Last year, he was appointed a GlobalScot in the animal health & aquaculture sector by the Office of the First Minister in Scotland.

Simon is a past president of the North of Ireland Veterinary Association and of the Northern Ireland Branch of BVA. He currently chairs the UK One Health Coordination Group and is one of two BVA representatives at the Federation of Veterinarians in Europe (FVE). He also chairs the FVE FishMedPlus Coalition.

A STEM Ambassador, he is also actively involved in the provision of veterinary careers advice, regularly mentoring applicants to veterinary school. He is also an ambassador for the livestock development charity, Send a Cow, and a trustee of the Animal Welfare Foundation.

Follow Simon on Twitter:
@simondocvet   @britishvets
#OneVeterinaryCommunity   #AStrongVoiceForVets

Partners

Platinum Digital Innovation Partner

Gold Digital Innovation Partner

Media Partners

The Agenda

Download the full agenda. 

Simply fill in this form and we'll send you a PDF version immediately. We need some information to know where to send the file and how to address our email to you. 

Download Agenda

Conference Packages

Sending Your Team? Group Discounts Available!

Applicable for Primary Market, Service Provider and Industry Rates Only. Not available for Academic or ‘Start-Up’ rates

Book a Team of 3+ - Save an Additional 10% Off
Book a Team of 5+ - Save an Additional 15% Off

If you would like to register a team of 3 or more, please email [email protected] for your discount coupon code before registering. PLEASE NOTE: Discounts cannot be combined with Early Bird Pricing or any other discount or offer. If you have any questions about your registration, please call us on +44 (0)20 3696 2920

We accept the following cards through Stripe:
Saturday, May 23, 2020 to Friday, June 26, 2020
Tier One
$699
Standard Rate
Start-Ups
Academics
Charities
Angel and Venture Capital Investors
Please note: Service providers do not qualify for this rate
Saturday, May 23, 2020 to Friday, June 26, 2020
Tier Two
$1799
Standard Rate
Corporate Entities
Investment Bankers
Service Providers
Consultants
To increase your brand presence, contact Stephen: [email protected]
Preparing registration...
Payment Terms for Animal Health Investment Online:
  • Please note that a $70 processing fee will apply to any invoices requested.
  • Any questions about your registration, please call +44 (0)20 3696 2920 or email us at [email protected].
  • All Prices are in USD
  • All Early Bird discount prices, including Group Discounts, must be paid in full by deadlines provided above.
  • No discounts or offers can be combined.
  • Please view our Cancellation Policy.
  • Emerging Companies are defined as early to mid-stage animal health pharmaceutical or biotech companies that are actively seeking financial investment or product licensing/acquisition. They must be engaged with this company on a full time basis. Those offering consultancy or market intelligence services do not qualify for this rate.
  • Please Note: No additional discounts are available on ‘Emerging Company’ pricing.

Global Advisory Board

Marc Prikazsky

Chairman and Chief Executive Officer
CEVA Santé Animale S.A

Rob Kelly

Executive Vice President International Operations
Zoetis Inc.

Aaron Schacht

Executive Vice President - Innovation, Regulatory & Business Development
Elanco

Sébastien Huron

Chairman of the Executive Board
Virbac Santé Animale

Jean-Luc Michel

Head of Global Strategic Marketing
Boehringer Ingelheim

Kathy V. Turner

Corporate Vice President and Global Chief Marketing Officer
IDEXX

George Gunn

Founder and CEO
Stonehaven Consulting AG

Linda Rhodes

Independent Animal Health Expert

Alan Mackay

Executive Partner and Founder
GHO Capital

Dave Ross

Chief Executive Officer
Agri-EPI Centre Ltd

Become a Sponsor

Kisaco Research provides the much-needed platform on which industry executives can network, connect and learn from each other as well as meet potential industry partners.

Far from the typical ‘meet-and-greet’ exhibition experience, you – as a sponsor or exhibitor – will be positioned as a partner of the event with a focus on the benefits of your product and brand, rather than just a name on an exhibition list.

With our extensive marketing experience and strategy, your partnership with Kisaco Research will grant you a sponsorship package that is an extension and enhancement of your current marketing and branding efforts. We value your ROI and will work with you directly on your specific goals and targets – that’s why we take special care in finding the most relevant end-users to attend, so that your financial and resource investment is smartly allocated.

Find out more by calling us at +44 (0)20 3696 2920 or email us at [email protected].

About Kisaco Research

Kisaco Research produces, designs and hosts B2B industry conferences, exhibitions and communities – focused on a specialized selection of topic areas.

Meet industry peers that will help build a career-changing network for life.

Learn from the mistakes of your peers as much as their successes—ambitious industry stalwarts who are happy to share not just what has made them successful so far but also their plans for future proofing their companies.

Note down the inspired insight that will form the foundation for future strategies and roadmaps, both at our events and through our online communities.

Invest both in your company growth and your own personal development by signing up to one of our events and get started.